Status:

TERMINATED

Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDL

Lead Sponsor:

Xavier Pinto Sala

Conditions:

Dyslipidemias

Eligibility:

All Genders

25+ years

Phase:

PHASE4

Brief Summary

Patients with premature ischemic heart disease (PIHD) and elevated levels of HDL-C present an altered composition of high-density lipoproteins (HDL) which is associated with a loss of their anti-ather...

Eligibility Criteria

Inclusion

  • Being male or female
  • Age \> 25 years
  • Have an episode of ischemic heart disease before 55 years in men and in women 65 years
  • Serum HDL-C above the 90th percentile of the Spanish population: \>=2.0mmol/L in women and \>=1.8mmol/L in men (Gomez-Gerique JA, et al. Med Clin (Barc.). 1999, 113: 730-735.)
  • Stable treatment with any statin in the past 6 weeks: simvastatin, atorvastatin, rosuvastatin, pravastatin or lovastatin.

Exclusion

  • Uncontrolled hypercholesterolemia or hypertriglyceridemia, LDL-C \>2.6mmol/L or triglycerides \>2.24mmol/L
  • Patients with an episode of ischemic heart disease in the last 3 months
  • Patients suffering from acute or chronic inflammatory diseases in the last 3 months
  • Treatment with fibrates or omega-3 fatty acids.
  • Treatment with steroids or immunosuppressive drugs
  • Patients with a contraindication to Tredaptive (Hypersensitivity to the active substances or any of the excipients, significant or unexplained hepatic dysfunction, active peptic ulcer, arterial bleeding).
  • Patients treated with drugs that may interact with Tredaptive (Midazolam).

Key Trial Info

Start Date :

July 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2013

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT01450410

Start Date

July 1 2012

End Date

May 1 2013

Last Update

January 29 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Unitat Funcional de Risc Vascular. Servei Medicina Interna. Hospital Universitari de Bellvitge.

L'Hospitalet de Llobregat, Barcelona, Spain, 08907